|Table of Contents|

The application value of acoustic pulse radiative power technology combined with BIRADS in the differential diagnosis of mammary tumors

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2019 02
Page:
294-297
Research Field:
Publishing date:

Info

Title:
The application value of acoustic pulse radiative power technology combined with BIRADS in the differential diagnosis of mammary tumors
Author(s):
Li Huan1; Ye Xinhua2
1.Department of Ultrasound Diagnosis,Changzhou Second People's Hospital Affiliated to Nanjing Medical University，Jiangsu Changzhou 213003，China；2.Department of Ultrasound Diagnosis,the First Affiliated Hospital of Nanjing Medical University，Jiangsu Nanjing 210029，China.
Keywords:
mammary tumors; ultrasonic diagnosis; ARFI; BIRADS
PACS:
R737.9
DOI:
10.3969/j.issn.1672-4992.2019.02.028
Abstract:
Objective:To examine the application value of acoustic pulse radiative technology (ARFI) and ultrasonic BIRADS classification in benign and malignant breast tumors.Methods:One hundred and six breast lesions in 82 women were evaluated with ultrasonography using ARFI and BIRADS.Pathologic results of all lesions were available.The obtained data was analyzed using an appropriate statistical test.Results：The specificity,sensitivity,positive predictive value,negative predictive value and accuracy were 96%,98.8%,96%,98.8% and 98.1% respectively when using AFRI combined with BIRADS for the diagnosis of mammary tumors.The Kappa value was 0.948.The specificity,sensitivity,positive predictive value,negative predictive value and accuracy were 88%,96.3%,88%,96.3% and 94.3%respectively,with ARFI for the diagnosis of mammary tumors respectively,and the Kappa value was 0.843.The specificity,sensitivity,positive predictive value,negative predictive value and accuracy of the diagnosis of benign malignancy were 84%,95.1%,84%,95.1%,92.5% respectively,with BIRADS for the diagnosis of mammary tumors respectively and the Kappa value of 0.791.The diagnostic efficacy of ARFI combined with BIRADS classification was statistically significant compared with the use of ARFI and BIRADS alone.Conclusion：The accuracy of diagnosis for the mammary tumor can be improved by using ARFI combined with BIRADS,which is worth for popularizing.

References:

［1］ Wiratkapun C,Bunyapaiboonsri W,Wibulpolprasert B,et al.Biopsy rate and positive predictive value for breast cancer in BI-RADS category 4 breast lesions［J］.J Med Assoc Thai,2010,93(7):830-837.
［2］ Lavoue V,Fritel X,Chopier J,et al.Clinical practice guidelines:Benign breast tumor-aims,methods and organization［J］.J Gynecol Obstet Biol Reprod (Paris),2015,44(10):898-903.
［3］ Chen Zhen,Zhu Wei.Analysis of ultrasonic diagnosis of benign malignant tumor in breast［J］.Chinese and Foreign Medical Research,2016,24:59-60.［程珍，诸玮.乳腺良恶性肿块超声诊断特点分析［J］.中外医学研究,2016,24:59-60.］
［4］ Liping Wang,Tianan Jiang，Chen Yang,et al.Reliability investigation and influential factors analysis of BI-RADS-ultrasound categorization on the benign breast nodules［J］.Chinese Journal of Ultrasonography,2011,20(4):314-317.［王立平，蒋天安，杨琛，等.乳腺良性结节超声BI-RADS分级的可靠性及其影响因素分析［J］.中华超声影像学杂志,2011,20(4):314-317.］
［5］ Kuo CS,Chen GR,Hung SH,et al.Women with abnormal screening mammography lost to follow-up:An experience from Taiwan［J］.Medicine (Baltimore),2016,95(24):e3889.
［6］ Yan Wang,Hui Wang,Xiaoxia Zha.The value of color Doppler ultrasound in breast tumor BI-RADS classification［J］.Journal of Modern Oncology,2015,23(03):403-406.［王艳，王辉，查晓霞.BI-RADS分级在彩超检查乳腺良、恶性肿瘤中的规范化应用［J］.现代肿瘤医学,2015,23(03):403-406.］
［7］ Wu S,Cui X,Huang L,et al.Combining virtual touch tissue imaging and BI-RADS may improve solid breast lesion evaluation［J］.Breast Care (Basel),2017,12(2):98-101.
［8］ Zhiwei Zhang,Xuesong Qian.Principle and clinical application of ARFI technology for ACUSON S2000 color doppler ultrasonograph［J］.Chinese Medical Equipment Journal,2012,8:125-126.［张志伟，钱雪松.ACUSON S2000彩色多普勒超声诊断仪ARFI技术原理及临床应用［J］.医疗卫生装备,2012,8:125-126.］
［9］ Jayaraman J,Indiran V,Kannan K,et al.Acoustic radiation force impulse imaging in benign and malignant breast Lesions［J］.Cureus,2017,9(6):e1301.
［10］ Liu B,Zheng Y,Shan Q,et al.Elastography by acoustic radiation force impulse technology for differentiation of benign and malignant breast lesions:A Meta-analysis［J］.J Med Ultrason,2016,43(1):47-55.
［11］ Li Y,Liu C,Geng J,et al.The texture quantitative analysis of the normal mammary parenchyma and in breast lesions:acoustic radiation force impulse (ARFI) technology［J］.Eur J Gynaecol Oncol,2014,35(3):274-279.
［12］ Jie Zhang,Xiufang Sui,Lei Wang,et al.Diagnostic value of acoustic radiation force impulse imaging in breast tumor［J］.Chongqing medical,2016,30:4237-4239.［张杰，隋秀芳，王磊，等.声脉冲辐射力成像对乳腺肿瘤的诊断价值［J］.重庆医学,2016,30:4237-4239.］
［13］Hu Yeshen,Hu Pingxiang,Zhang Hexiang,et al.Value of acoustic radiation force impulse imaging in diagnosis of benign and malignant breast lesions［J］.Chinese Imaging Journal of Integrated Traditional and Western Medicine,2016,2:176-178.［胡业深，胡萍香，张贺香，等.声脉冲辐射力成像对乳腺良恶性结节的鉴别诊断价值［J］.中国中西医结合影像学杂志,2016,2:176-178.］
［14］ Magalhaes M,Belo-Oliveira P,Casalta-Lopes J,et al.Diagnostic value of ARFI (Acoustic Radiation Force Impulse) in differentiating benign from malignant breast lesions［J］.Acad Radiol,2017,24(1):45-52.
［15］ Pu H,Zhao LX,Yao MH,et al.Conventional US combined with acoustic radiation force impulse (ARFI) elastography for prediction of triple-negative breast cancer and the risk of lymphatic metastasis［J］.Clin Hemorheol Microcirc,2017,65(4):335-347.

Memo

Memo:
-
Last Update: 1900-01-01